Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Molecular Detection and Integrated Sciences Announce Distribution Agreement for Detect-Ready™ MRSA Assay in Australia

September 22, 2010 By Bio-Medicine.Org

WAYNE, Pa. and SYDNEY, Sept. 22 /PRNewswire/ — Molecular
Detection Inc. (MDI), a company developing Detect-Ready™
assays designed to increase the speed and accuracy of infectious
disease diagnosis, and Integrated Sciences Pty. Ltd. today
announced that they have entered into an exclusive distribution
agreement for MDI’s Detect-Ready MRSA assay in Australia.  The
Detect-Ready MRSA assay offers healthcare providers a
high-performance MRSA screening test with an unmatched combination
of accuracy, speed, flexibility and cost-effectiveness.
 Integrated Sciences recently launched the Detect-Ready MRSA
assay into the Australian market.

“This latest agreement continues our strategy of partnering our
Detect-Ready MRSA assay with leading distributors worldwide,” said
Todd Wallach, CEO of MDI.  “The Detect-Ready MRSA assay offers
important advantages, and we believe that Integrated Sciences’
focus on top-quality customer service and expert technical support,
along with its national reach, will help our Detect-Ready assay
achieve strong acceptance in the growing Australian market for MRSA
screening.”

Drug-resistant, potentially deadly MRSA (methicillin-resistant
Staphylococcus aureus) infections are a growing problem in
healthcare facilities around the world.  The Detect-Ready MRSA
kit is a qualitative real-time PCR (rt-PCR) in vitro
diagnostic test for the direct detection of MRSA nasal colonization
to aid in the prevention and control of MRSA infections in
hospitals and other healthcare settings.  The proprietary
technology in the Detect-Ready kits provides a unique differential
diagnosis engine that produces highly accurate results, minimizing
the false positives and false negatives experienced with other MRSA
screening kits.  Samples for testing are simple to obtain
using nasal swabs and the assay’s ready-to-use pre-mixed reagents
require only the addition of patient sample to run the test, which
provides r

‘/>”/>

SOURCE

Related Articles Read More >

Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech